Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Increased myofibroblasts in the small airways, and relationship to remodelling and functional changes in smokers and COPD patients: potential role of epithelial–mesenchymal transition

Mathew Suji Eapen, Wenying Lu, Tillie L. Hackett, Gurpreet Kaur Singhera, Malik Q. Mahmood, Ashutosh Hardikar, Chris Ward, Eugene Haydn Walters, Sukhwinder Singh Sohal
ERJ Open Research 2021 7: 00876-2020; DOI: 10.1183/23120541.00876-2020
Mathew Suji Eapen
1Respiratory Translational Research Group, Dept of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mathew Suji Eapen
Wenying Lu
1Respiratory Translational Research Group, Dept of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tillie L. Hackett
2Dept of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC, Canada
3UBC Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gurpreet Kaur Singhera
3UBC Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, Canada
4Dept of Medicine, University of British Columbia, Vancouver, BC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Malik Q. Mahmood
5School of Medicine, Deakin University, Waurn Ponds, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashutosh Hardikar
1Respiratory Translational Research Group, Dept of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia
6Dept of Cardiothoracic Surgery, Royal Hobart Hospital, Hobart, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chris Ward
7Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eugene Haydn Walters
8School of Medicine, and Menzies Institute of Medical Research, College of Health and Medicine, University of Tasmania, Hobart, Tasmania, Australia
9These authors contributed equally
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sukhwinder Singh Sohal
1Respiratory Translational Research Group, Dept of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Australia
9These authors contributed equally
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sssohal@utas.edu.au
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Figures

  • Tables
  • Supplementary Materials
  • FIGURE 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1

    Representative images of the full airway wall thickness in the small airway wall of a) normal control (NC) and b) COPD. An increase in thickness was observed in the clinical (smoker/COPD) groups in the c) lamina propria (LP), d) adventitia and e) smooth muscle (SM) layer. NLFS: normal lung function smoker; COPD-CS: COPD current smoker; COPD-ES: COPD ex-smoker. Scale bars=50 μm. **: p<0.01, ***: p<0.001.

  • FIGURE 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2

    Correlation between airway wall thickness and lung function indices: a) forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC) and b) forced expiratory flow at 25–75% of FVC (FEF25–75%) (more specific for small airways (SA)) in the combined COPD groups. LP: lamina propria.

  • FIGURE 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3

    Representative images of α-smooth muscle actin (SMA)+ cells in the airway wall of a) normal control (NC), normal lung function smoker (NLFS) and COPD current (CS) and ex-smokers (ES). Increase in small airway (SA) αSMA+ cells were observed in all three sublayers of the subepithelial areas of the small airway wall: b) reticular basement membrane (Rbm); c) lamina propria (LP); and d) adventitia. Scale bars=50 μm. *: p<0.05, **: p<0.01, ***: p<0.001.

  • FIGURE 4
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4

    Representative images of collagen-1 and fibronectin deposition by percentage area in the airway wall of a) normal control (NC), normal lung function smoker (NLFS) and COPD current (CS) and ex-smokers (ES), with increases in percentage collagen-1 and fibronectin expression in pathological groups in both the b,d) lamina propria (LP) and c,e) adventitia, with both CS and COPD effects. SA: small airway. Scale bars=50 μm. *: p<0.05, **: p<0.01, ***: p<0.001.

  • FIGURE 5
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5

    Correlations between α-smooth muscle actin (SMA)+ myofibroblasts in the a, c) reticular basement membrane (Rbm) and b, d) lamina propria (LP) of the three smoking/COPD groups (normal lung function smoker (NLFS) and COPD current (CS) and ex-smokers (ES)) and indices of airflow, done independently: a, b) forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC) ratio and c, d) forced expiratory flow at 25–75% of FVC (FEF25–75%); e) correlation between number of myofibroblasts and thickness of LP among the combined pathological groups. SA: small airway; r′: Spearman's r.

  • FIGURE 6
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 6

    Correlations between the epithelial–mesenchymal transition (EMT) marker S100A4+ expression in the a) basal epithelial cells and b) reticular basement membrane (Rbm), with α-smooth muscle actin (SMA)+ cells within both small airway (SA) wall and the Rbm; and between the two EMT markers c) S100A4 and d) vimentin expressed in basal epithelial cells and lamina propria (LP) thickening.

Tables

  • Figures
  • Supplementary Materials
  • TABLE 1

    Patient demographics

    NCNLFSCOPD-CSCOPD-ES
    Subjects1011910
    Age years50 (19–73)69 (52–79)**65 (59–78)**68 (56–85)**
    Smoking history pack-yearsNS27 (0.3–40)30 (2–48)30 (2–58)
    FEV1/FVC %#N/A76 (70–90)66 (59.9–70)64 (55–69)
    FEF25–75%#N/A79 (47–116)37 (28–47)41 (20–55)

    Data are presented as n or median (range). NC: normal control; NLFS: normal lung function smoker; COPD-CS: COPD current smoker; COPD-ES: COPD ex-smoker; FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; FEF25–75%: forced expiratory flow at 25–75% of FVC; NS: nonsmokers; N/A: not available. #: post-bronchodilator values after 400 µg salbutamol. **: p<0.01 over NC (ordinary one-way ANOVA followed by Dunnett's multiple comparison test).

    • TABLE 2

      Correlation of extracellular matrix proteins (collagen-1 and fibronectin) with lung function and small airway lamina propria thickness

      NLFSCOPD-CSCOPD-ES
      Collagen-1 in lamina propria area versus lung function (FEV1/FVC)r′=−0.64
      p<0.05
      r′=0.35
      p-value ns
      Fibronectin in lamina propria area versus lung function (FEV1/FVC)r′=0.35
      p-value ns
      r′=0.007
      p-value ns
      Collagen-1 in lamina propria area versus airway wall lamina propria thickness (μm)r′=0.05
      p-value ns
      r′=0.59
      p<0.05
      r′=0.37
      p<0.05
      Fibronectin in lamina propria area versus airway wall lamina propria thickness (μm)r′=0.4
      p-value ns
      r′=−0.01
      p-value ns
      r′=−0.01
      p-value ns

      NLFS: normal lung function smoker; COPD-CS: COPD current smoker; COPD-ES: COPD ex-smoker; FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; r′: Spearman's r; ns: nonsignificant.

      Supplementary Materials

      • Figures
      • Tables
      • Supplementary Material

        Please note: supplementary material is not edited by the Editorial Office, and is uploaded as it has been supplied by the author.

        Supplementary material 00876-2020.SUPPLEMENT

      PreviousNext
      Back to top
      Vol 7 Issue 2 Table of Contents
      ERJ Open Research: 7 (2)
      • Table of Contents
      • Index by author
      Email

      Thank you for your interest in spreading the word on European Respiratory Society .

      NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

      Enter multiple addresses on separate lines or separate them with commas.
      Increased myofibroblasts in the small airways, and relationship to remodelling and functional changes in smokers and COPD patients: potential role of epithelial–mesenchymal transition
      (Your Name) has sent you a message from European Respiratory Society
      (Your Name) thought you would like to see the European Respiratory Society web site.
      CAPTCHA
      This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
      Print
      Citation Tools
      Increased myofibroblasts in the small airways, and relationship to remodelling and functional changes in smokers and COPD patients: potential role of epithelial–mesenchymal transition
      Mathew Suji Eapen, Wenying Lu, Tillie L. Hackett, Gurpreet Kaur Singhera, Malik Q. Mahmood, Ashutosh Hardikar, Chris Ward, Eugene Haydn Walters, Sukhwinder Singh Sohal
      ERJ Open Research Apr 2021, 7 (2) 00876-2020; DOI: 10.1183/23120541.00876-2020

      Citation Manager Formats

      • BibTeX
      • Bookends
      • EasyBib
      • EndNote (tagged)
      • EndNote 8 (xml)
      • Medlars
      • Mendeley
      • Papers
      • RefWorks Tagged
      • Ref Manager
      • RIS
      • Zotero
      Share
      Increased myofibroblasts in the small airways, and relationship to remodelling and functional changes in smokers and COPD patients: potential role of epithelial–mesenchymal transition
      Mathew Suji Eapen, Wenying Lu, Tillie L. Hackett, Gurpreet Kaur Singhera, Malik Q. Mahmood, Ashutosh Hardikar, Chris Ward, Eugene Haydn Walters, Sukhwinder Singh Sohal
      ERJ Open Research Apr 2021, 7 (2) 00876-2020; DOI: 10.1183/23120541.00876-2020
      del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
      Full Text (PDF)

      Jump To

      • Article
        • Abstract
        • Abstract
        • Introduction
        • Materials and methods
        • Results
        • Discussion
        • Supplementary material
        • Footnotes
        • References
      • Figures & Data
      • Info & Metrics
      • PDF

      Subjects

      • COPD and smoking
      • Lung biology and experimental studies
      • Tweet Widget
      • Facebook Like
      • Google Plus One

      More in this TOC Section

      Original articles

      • Characteristics and impact of EILO
      • A common model for the breathlessness experience
      • Endobronchial autologous BM-MSCs in IPF patients
      Show more Original articles

      COPD

      • Dysregulation of TLR2 signalling in COPD
      • Application of the Rome severity classification
      • Multiomics: surfactant dysregulation in COPD
      Show more COPD

      Related Articles

      Navigate

      • Home
      • Current issue
      • Archive

      About ERJ Open Research

      • Editorial board
      • Journal information
      • Press
      • Permissions and reprints
      • Advertising

      The European Respiratory Society

      • Society home
      • myERS
      • Privacy policy
      • Accessibility

      ERS publications

      • European Respiratory Journal
      • ERJ Open Research
      • European Respiratory Review
      • Breathe
      • ERS books online
      • ERS Bookshop

      Help

      • Feedback

      For authors

      • Instructions for authors
      • Publication ethics and malpractice
      • Submit a manuscript

      For readers

      • Alerts
      • Subjects
      • RSS

      Subscriptions

      • Accessing the ERS publications

      Contact us

      European Respiratory Society
      442 Glossop Road
      Sheffield S10 2PX
      United Kingdom
      Tel: +44 114 2672860
      Email: journals@ersnet.org

      ISSN

      Online ISSN: 2312-0541

      Copyright © 2023 by the European Respiratory Society